Cargando…

Neurofilamentopathy in Neurodegenerative Diseases

Neurofilament protein alterations are found in many neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson, Alzheimer, and Charcot-Marie-Tooth. Abnormal modifications of neurofilament, such as mutation, oxidation and phosphorylation, are linked to the disease-related alteration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Quan, Xie, Fang, Alvarado-Diaz, Abdiel, Smith, Mark A, Moreira, Paula I, Zhu, Xiongwei, Perry, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170930/ https://www.ncbi.nlm.nih.gov/pubmed/21915226 http://dx.doi.org/10.2174/1874205X01105010058

Ejemplares similares

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Oxidative Damage to RNA in Neurodegenerative Diseases
por: Nunomura, Akihiko, et al.
Publicado: (2006)

Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease
por: Castellani, Rudy J., et al.
Publicado: (2008)

Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases
por: Liu, Yi, et al.
Publicado: (2017)

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013)

Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria
por: Dwyer, Barney E., et al.
Publicado: (2006)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
por: Castellani, Rudy J., et al.
Publicado: (2009)

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
por: Cardoso, Susana, et al.
Publicado: (2009)

Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases
por: Plascencia-Villa, Germán, et al.
Publicado: (2023)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

Mitochondrial Preconditioning: A Potential Neuroprotective Strategy
por: Correia, Sónia C., et al.
Publicado: (2010)

The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
por: Obrenovich, Mark, et al.
Publicado: (2020)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
por: Casadesus, Gemma, et al.
Publicado: (2007)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease
por: Bryan, Kathryn J, et al.
Publicado: (2008)

Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events
por: Carvalho, Cristina, et al.
Publicado: (2018)

Hibernation, a Model of Neuroprotection
por: Zhou, Fang, et al.
Publicado: (2001)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Global warming and neurodegenerative disorders: speculations on their linkage
por: Habibi, Laleh, et al.
Publicado: (2014)

Vitamin C is a source of oxoaldehyde and glycative stress in age‐related cataract and neurodegenerative diseases
por: Fan, Xingjun, et al.
Publicado: (2020)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases
por: Williams, Wesley M., et al.
Publicado: (2011)

A Perspective on the Link between Mitochondria-Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases
por: Fernandes, Tânia, et al.
Publicado: (2023)

BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007)

Microglia in neurodegenerative diseases
por: Xu, Yu, et al.
Publicado: (2020)

GSK-3 in Neurodegenerative Diseases
por: Lei, Peng, et al.
Publicado: (2011)

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
por: Gao, Ju, et al.
Publicado: (2017)

Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases
por: Du, Ming-Rui, et al.
Publicado: (2022)

Targeted Oligonucleotides for Treating Neurodegenerative Tandem Repeat Diseases
por: Zain, Rula, et al.
Publicado: (2019)

Birth of JAD: 20 Years Later
por: Perry, George, et al.
Publicado: (2018)

Human brain single nucleus cell type enrichments in neurodegenerative diseases
por: Alvarado, Chelsea X, et al.
Publicado: (2023)

Class A and C GPCR Dimers in Neurodegenerative Diseases
por: Caniceiro, Ana B., et al.
Publicado: (2022)

Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
por: Luo, Fang, et al.
Publicado: (2020)

Endothelial Dysfunction in Neurodegenerative Diseases
por: Fang, Yao-Ching, et al.
Publicado: (2023)

Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases
por: Manca, Matteo, et al.
Publicado: (2023)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Brain structure and structural basis of neurodegenerative diseases
por: Yang, Jiawen, et al.
Publicado: (2022)

Implications of Gut Microbiota in Neurodegenerative Diseases
por: Zhang, Haoming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_su7edrhckff0c7glcd1vktep31